Cutera, Inc. Logo

Cutera, Inc.

CUTR

(2.0)
Stock Price

0,36 USD

-49.81% ROA

63.25% ROE

-0.1x PER

Market Cap.

13.978.757,00 USD

-196.57% DER

0% Yield

-84.86% NPM

Cutera, Inc. Stock Analysis

Cutera, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Cutera, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (284.07%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

With a remarkably low PBV ratio (-0.66x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a low debt to equity ratio (-622%), which means it has a small amount of debt compared to the ownership it holds

4 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

5 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (62), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

6 ROA

The stock's ROA (-16.56%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

7 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

9 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

10 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

11 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

Cutera, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Cutera, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

Cutera, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Cutera, Inc. Revenue
Year Revenue Growth
2000 9.531.000
2001 19.328.000 50.69%
2002 28.327.000 31.77%
2003 39.088.000 27.53%
2004 52.641.000 25.75%
2005 75.620.000 30.39%
2006 100.692.000 24.9%
2007 101.726.000 1.02%
2008 83.379.000 -22%
2009 53.682.000 -55.32%
2010 53.274.000 -0.77%
2011 60.290.000 11.64%
2012 77.277.000 21.98%
2013 74.594.000 -3.6%
2014 78.138.000 4.54%
2015 94.761.000 17.54%
2016 118.056.000 19.73%
2017 151.493.000 22.07%
2018 162.720.000 6.9%
2019 181.712.000 10.45%
2020 147.683.000 -23.04%
2021 231.270.000 36.14%
2022 252.399.000 8.37%
2023 244.872.000 -3.07%
2023 212.369.000 -15.3%
2024 137.508.000 -54.44%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Cutera, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2000 1.539.000
2001 2.108.000 26.99%
2002 2.988.000 29.45%
2003 3.448.000 13.34%
2004 4.136.000 16.63%
2005 5.065.000 18.34%
2006 6.473.000 21.75%
2007 7.169.000 9.71%
2008 7.550.000 5.05%
2009 6.810.000 -10.87%
2010 7.004.000 2.77%
2011 9.141.000 23.38%
2012 8.427.000 -8.47%
2013 9.216.000 8.56%
2014 10.543.000 12.59%
2015 10.733.000 1.77%
2016 11.232.000 4.44%
2017 12.874.000 12.75%
2018 14.359.000 10.34%
2019 15.085.000 4.81%
2020 14.322.000 -5.33%
2021 21.568.000 33.6%
2022 25.155.000 14.26%
2023 23.136.000 -8.73%
2023 21.408.000 -8.07%
2024 17.852.000 -19.92%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Cutera, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2000 989.000
2001 0 0%
2002 5.416.000 100%
2003 18.159.000 70.17%
2004 27.396.000 33.72%
2005 32.784.000 16.43%
2006 48.082.000 31.82%
2007 49.998.000 3.83%
2008 46.624.000 -7.24%
2009 10.320.000 -351.78%
2010 9.576.000 -7.77%
2011 10.104.000 5.23%
2012 11.276.000 10.39%
2013 9.938.000 -13.46%
2014 11.203.000 11.29%
2015 12.129.000 7.63%
2016 12.943.000 6.29%
2017 14.090.000 8.14%
2018 20.995.000 32.89%
2019 24.033.000 12.64%
2020 31.512.000 23.73%
2021 32.945.000 4.35%
2022 45.917.000 28.25%
2023 74.112.000 38.04%
2023 63.313.000 -17.06%
2024 17.284.000 -266.31%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Cutera, Inc. EBITDA
Year EBITDA Growth
2000 844.000
2001 2.510.000 66.37%
2002 1.712.000 -46.61%
2003 5.607.000 69.47%
2004 7.112.000 21.16%
2005 17.979.000 60.44%
2006 17.147.000 -4.85%
2007 10.470.000 -63.77%
2008 1.305.000 -702.3%
2009 -7.783.000 116.77%
2010 -10.382.000 25.03%
2011 -9.815.000 -5.78%
2012 -5.221.000 -87.99%
2013 -3.952.000 -32.11%
2014 -9.283.000 57.43%
2015 -3.335.000 -178.35%
2016 3.379.000 198.7%
2017 4.092.000 17.42%
2018 -12.183.000 133.59%
2019 -10.516.000 -15.85%
2020 -21.434.000 50.94%
2021 58.000 37055.17%
2022 -38.000.000 100.15%
2023 -106.124.000 64.19%
2023 -145.508.000 27.07%
2024 -74.488.000 -95.34%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Cutera, Inc. Gross Profit
Year Gross Profit Growth
2000 6.166.000
2001 12.387.000 50.22%
2002 18.336.000 32.44%
2003 26.771.000 31.51%
2004 37.952.000 29.46%
2005 55.828.000 32.02%
2006 70.833.000 21.18%
2007 66.724.000 -6.16%
2008 51.021.000 -30.78%
2009 31.923.000 -59.83%
2010 30.216.000 -5.65%
2011 34.312.000 11.94%
2012 41.540.000 17.4%
2013 41.882.000 0.82%
2014 43.373.000 3.44%
2015 54.283.000 20.1%
2016 68.135.000 20.33%
2017 86.110.000 20.87%
2018 80.382.000 -7.13%
2019 98.163.000 18.11%
2020 75.772.000 -29.55%
2021 133.105.000 43.07%
2022 139.829.000 4.81%
2023 112.216.000 -24.61%
2023 41.494.000 -170.44%
2024 25.064.000 -65.55%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Cutera, Inc. Net Profit
Year Net Profit Growth
2000 1.037.000
2001 2.339.000 55.66%
2002 660.000 -254.39%
2003 3.106.000 78.75%
2004 3.760.000 17.39%
2005 13.801.000 72.76%
2006 2.123.000 -550.07%
2007 10.504.000 79.79%
2008 -2.869.000 466.12%
2009 -17.679.000 83.77%
2010 -10.518.000 -68.08%
2011 -10.061.000 -4.54%
2012 -6.548.000 -53.65%
2013 -4.747.000 -37.94%
2014 -10.612.000 55.27%
2015 -4.440.000 -139.01%
2016 2.577.000 272.29%
2017 29.993.000 91.41%
2018 -30.770.000 197.47%
2019 -12.348.000 -149.19%
2020 -23.877.000 48.28%
2021 2.062.000 1257.95%
2022 -82.340.000 102.5%
2023 -126.576.000 34.95%
2023 -162.833.000 22.27%
2024 -98.724.000 -64.94%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Cutera, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2000 0
2001 0 0%
2002 0 0%
2003 1 100%
2004 0 0%
2005 1 100%
2006 0 0%
2007 1 0%
2008 0 0%
2009 -1 100%
2010 -1 0%
2011 -1 0%
2012 0 0%
2013 0 0%
2014 -1 0%
2015 0 0%
2016 0 0%
2017 2 100%
2018 -2 200%
2019 -1 0%
2020 -1 100%
2021 0 0%
2022 -4 100%
2023 -6 33.33%
2023 -8 25%
2024 -5 -100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Cutera, Inc. Free Cashflow
Year Free Cashflow Growth
2002 1.859.000
2003 1.996.000 6.86%
2004 8.390.000 76.21%
2005 19.849.000 57.73%
2006 10.606.000 -87.15%
2007 15.870.000 33.17%
2008 3.637.000 -336.35%
2009 -113.000 3318.58%
2010 -8.334.000 98.64%
2011 -5.919.000 -40.8%
2012 -2.816.000 -110.19%
2013 2.841.000 199.12%
2014 -5.020.000 156.59%
2015 -2.105.000 -138.48%
2016 1.455.000 244.67%
2017 13.432.000 89.17%
2018 -1.181.000 1237.34%
2019 -3.208.000 63.19%
2020 -18.235.000 82.41%
2021 220.000 8388.64%
2022 -89.693.000 100.25%
2023 -46.021.000 -94.9%
2023 -170.879.999 73.07%
2024 -21.126.000 -708.86%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Cutera, Inc. Operating Cashflow
Year Operating Cashflow Growth
2002 2.677.000
2003 2.585.000 -3.56%
2004 9.244.000 72.04%
2005 20.388.000 54.66%
2006 12.466.000 -63.55%
2007 16.890.000 26.19%
2008 4.340.000 -289.17%
2009 41.000 -10485.37%
2010 -8.059.000 100.51%
2011 -5.168.000 -55.94%
2012 -2.300.000 -124.7%
2013 3.513.000 165.47%
2014 -4.286.000 181.96%
2015 -1.359.000 -215.38%
2016 1.992.000 168.22%
2017 14.287.000 86.06%
2018 307.000 -4553.75%
2019 -2.217.000 113.85%
2020 -16.956.000 86.92%
2021 1.235.000 1472.96%
2022 -66.995.000 101.84%
2023 -31.266.000 -114.27%
2023 -137.870.000 77.32%
2024 -20.244.000 -581.04%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Cutera, Inc. Capital Expenditure
Year Capital Expenditure Growth
2002 818.000
2003 589.000 -38.88%
2004 854.000 31.03%
2005 539.000 -58.44%
2006 1.860.000 71.02%
2007 1.020.000 -82.35%
2008 703.000 -45.09%
2009 154.000 -356.49%
2010 275.000 44%
2011 751.000 63.38%
2012 516.000 -45.54%
2013 672.000 23.21%
2014 734.000 8.45%
2015 746.000 1.61%
2016 537.000 -38.92%
2017 855.000 37.19%
2018 1.488.000 42.54%
2019 991.000 -50.15%
2020 1.279.000 22.52%
2021 1.015.000 -26.01%
2022 22.698.000 95.53%
2023 14.755.000 -53.83%
2023 33.009.999 55.3%
2024 882.000 -3642.63%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Cutera, Inc. Equity
Year Equity Growth
2000 -1.918.000
2001 1.226.000 256.44%
2002 3.106.000 60.53%
2003 7.875.000 60.56%
2004 68.456.000 88.5%
2005 97.177.000 29.56%
2006 109.732.000 11.44%
2007 109.353.000 -0.35%
2008 112.108.000 2.46%
2009 100.853.000 -11.16%
2010 95.417.000 -5.7%
2011 91.567.000 -4.2%
2012 90.774.000 -0.87%
2013 84.265.000 -7.72%
2014 80.508.000 -4.67%
2015 50.034.000 -60.91%
2016 61.010.000 17.99%
2017 64.893.000 5.98%
2018 46.386.000 -39.9%
2019 45.942.000 -0.97%
2020 56.880.000 19.23%
2021 56.569.000 -0.55%
2022 -15.181.000 472.63%
2023 -69.135.000 78.04%
2023 -171.830.000 59.77%
2024 -215.671.000 20.33%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Cutera, Inc. Assets
Year Assets Growth
2000 7.038.000
2001 12.475.000 43.58%
2002 15.426.000 19.13%
2003 24.198.000 36.25%
2004 80.549.000 69.96%
2005 111.958.000 28.05%
2006 133.875.000 16.37%
2007 138.653.000 3.45%
2008 137.476.000 -0.86%
2009 121.352.000 -13.29%
2010 111.805.000 -8.54%
2011 111.353.000 -0.41%
2012 112.794.000 1.28%
2013 108.669.000 -3.8%
2014 108.913.000 0.22%
2015 77.518.000 -40.5%
2016 91.854.000 15.61%
2017 111.238.000 17.43%
2018 97.637.000 -13.93%
2019 113.738.000 14.16%
2020 132.733.000 14.31%
2021 280.293.000 52.64%
2022 520.988.000 46.2%
2023 463.830.000 -12.32%
2023 346.291.000 -33.94%
2024 276.295.000 -25.33%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Cutera, Inc. Liabilities
Year Liabilities Growth
2000 8.956.000
2001 11.249.000 20.38%
2002 12.320.000 8.69%
2003 16.323.000 24.52%
2004 12.093.000 -34.98%
2005 14.781.000 18.19%
2006 24.143.000 38.78%
2007 29.300.000 17.6%
2008 25.368.000 -15.5%
2009 20.499.000 -23.75%
2010 16.388.000 -25.09%
2011 19.786.000 17.17%
2012 22.020.000 10.15%
2013 24.404.000 9.77%
2014 28.405.000 14.09%
2015 27.484.000 -3.35%
2016 30.844.000 10.89%
2017 46.345.000 33.45%
2018 51.251.000 9.57%
2019 67.796.000 24.4%
2020 75.853.000 10.62%
2021 223.724.000 66.1%
2022 536.169.000 58.27%
2023 532.965.000 -0.6%
2023 518.121.000 -2.86%
2024 491.966.000 -5.32%

Cutera, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
8.42
Net Income per Share
-6.82
Price to Earning Ratio
-0.1x
Price To Sales Ratio
0.08x
POCF Ratio
-0.11
PFCF Ratio
-0.1
Price to Book Ratio
-0.06
EV to Sales
2.16
EV Over EBITDA
-3.05
EV to Operating CashFlow
-2.83
EV to FreeCashFlow
-2.65
Earnings Yield
-9.82
FreeCashFlow Yield
-9.86
Market Cap
0,01 Bil.
Enterprise Value
0,36 Bil.
Graham Number
40.58
Graham NetNet
-16.83

Income Statement Metrics

Net Income per Share
-6.82
Income Quality
0.94
ROE
0.79
Return On Assets
-0.56
Return On Capital Employed
-0.74
Net Income per EBT
1.01
EBT Per Ebit
0.99
Ebit per Revenue
-0.85
Effective Tax Rate
-0.01

Margins

Sales, General, & Administrative to Revenue
0.33
Research & Developement to Revenue
0.11
Stock Based Compensation to Revenue
0.04
Gross Profit Margin
0.15
Operating Profit Margin
-0.85
Pretax Profit Margin
-0.84
Net Profit Margin
-0.85

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-6.41
Free CashFlow per Share
-6.86
Capex to Operating CashFlow
-0.07
Capex to Revenue
0.05
Capex to Depreciation
0.59
Return on Invested Capital
-0.66
Return on Tangible Assets
-0.5
Days Sales Outstanding
79.71
Days Payables Outstanding
44.66
Days of Inventory on Hand
217.98
Receivables Turnover
4.58
Payables Turnover
8.17
Inventory Turnover
1.67
Capex per Share
0.45

Balance Sheet

Cash per Share
4,14
Book Value per Share
-10,73
Tangible Book Value per Share
-10.8
Shareholders Equity per Share
-10.73
Interest Debt per Share
21.74
Debt to Equity
-1.97
Debt to Assets
1.53
Net Debt to EBITDA
-2.93
Current Ratio
3.51
Tangible Asset Value
-0,22 Bil.
Net Current Asset Value
-0,28 Bil.
Invested Capital
191697000
Working Capital
0,15 Bil.
Intangibles to Total Assets
0
Average Receivables
0,04 Bil.
Average Payables
0,02 Bil.
Average Inventory
83095000
Debt to Market Cap
30.33

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Cutera, Inc. Dividends
Year Dividends Growth

Cutera, Inc. Profile

About Cutera, Inc.

Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was incorporated in 1988 and is headquartered in Brisbane, California.

CEO
Mr. Taylor C. Harris
Employee
430
Address
3240 Bayshore Boulevard
Brisbane, 94005

Cutera, Inc. Executives & BODs

Cutera, Inc. Executives & BODs
# Name Age
1 Mr. Brent Hauser
President of International
70
2 Greg Barker
Vice President of FP&A and Investor Relations
70
3 Mr. Steve Kreider
Senior Vice President of Global Marketing
70
4 Mr. Stuart D. Drummond
Chief Financial Officer
70
5 Dr. Stephana E. Patton J.D., Ph.D.
Chief Legal Officer
70
6 Mr. Taylor C. Harris
President, Chief Executive Officer & Director
70
7 Shelby Eckerman
Vice President of Finance
70
8 Mr. Charles G. Thier
Chief Information Officer
70
9 Mr. Jeffrey S. Jones
Chief Operating Officer
70

Cutera, Inc. Competitors

NeuroPace, Inc. Logo
NeuroPace, Inc.

NPCE

(0.5)
Inogen, Inc. Logo
Inogen, Inc.

INGN

(1.2)
Surmodics, Inc. Logo
Surmodics, Inc.

SRDX

(0.8)
Pulmonx Corporation Logo
Pulmonx Corporation

LUNG

(1.2)
CVRx, Inc. Logo
CVRx, Inc.

CVRX

(1.0)
Heska Corporation Logo
Heska Corporation

HSKA

(1.0)
NuVasive, Inc. Logo
NuVasive, Inc.

NUVA

(1.0)
CONMED Corporation Logo
CONMED Corporation

CNMD

(1.5)
SI-BONE, Inc. Logo
SI-BONE, Inc.

SIBN

(1.0)
Paragon 28, Inc. Logo
Paragon 28, Inc.

FNA

(1.5)
ProSomnus, Inc. Logo
ProSomnus, Inc.

OSA

(2.2)
LivaNova PLC Logo
LivaNova PLC

LIVN

(2.2)
Electromed, Inc. Logo
Electromed, Inc.

ELMD

(2.0)